S&P 500

5.514,54

0,10%

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AMGN

Amgen (AMGN)

Amgen Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:BIT:AMGN

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/02/2010	00h20	PR Newswire (US)	Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me	NASDAQ:AMGN
25/01/2010	22h07	PR Newswire (US)	Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share	NASDAQ:AMGN
21/01/2010	15h00	PR Newswire (US)	Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium	NASDAQ:AMGN
20/01/2010	22h13	PR Newswire (US)	Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results	NASDAQ:AMGN
14/01/2010	18h57	PR Newswire (US)	Amgen Donates $2 Million, Establishes Earthquake Relief Program	NASDAQ:AMGN
07/01/2010	22h34	PR Newswire (US)	Amgen to Present at the 28th Annual JP Morgan Healthcare Conference	NASDAQ:AMGN
22/12/2009	22h04	PR Newswire (US)	Amgen Resolves EPO Patent Dispute With Roche	NASDAQ:AMGN
18/12/2009	22h40	PR Newswire (US)	Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines	NASDAQ:AMGN
07/12/2009	15h01	PR Newswire (US)	Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program	NASDAQ:AMGN
03/12/2009	19h04	PR Newswire (US)	New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists	NASDAQ:AMGN
30/11/2009	14h51	PR Newswire (US)	Amgen Highlights Data to be Presented at ASH	NASDAQ:AMGN
23/11/2009	21h05	PR Newswire (US)	Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards	NASDAQ:AMGN
17/11/2009	00h06	PR Newswire (US)	Amgen to Present at Lazard Capital Healthcare Conference	NASDAQ:AMGN
12/11/2009	15h01	PR Newswire (US)	Amgen to Present at 18th Annual Credit Suisse Healthcare Conference	NASDAQ:AMGN
05/11/2009	14h03	PR Newswire (US)	Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer	NASDAQ:AMGN
04/11/2009	18h22	PR Newswire (US)	Call for Applications: The Amgen Award for Science Teaching Excellence	NASDAQ:AMGN
31/10/2009	01h44	PR Newswire (US)	Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medic	NASDAQ:AMGN
21/10/2009	22h08	PR Newswire (US)	Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49	NASDAQ:AMGN
19/10/2009	20h57	Dow Jones News	2nd UPDATE: FDA Delays Decision On Amgen Bone Drug	NASDAQ:AMGN	Amgen Inc.
19/10/2009	17h17	Dow Jones News	UPDATE: FDA Delays Decision On Amgen Bone Drug For Added Info	NASDAQ:AMGN	Amgen Inc.
19/10/2009	15h55	Dow Jones News	FDA Seeks Added Info On Amgen Bone Drug, Delays Decision	NASDAQ:AMGN	Amgen Inc.
16/10/2009	20h55	Dow Jones News	US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches	NASDAQ:AMGN	Amgen Inc.
15/10/2009	22h42	PR Newswire (US)	Amgen Announces Webcast of 2009 Third Quarter Financial Results	NASDAQ:AMGN
14/10/2009	20h44	Dow Jones News	Amgen's Bone Drug May Face Delays In FDA Decision	NASDAQ:AMGN	Amgen Inc.
12/10/2009	16h57	Dow Jones News	Drug Stocks Edge Higher; DepoMed Sinks	NASDAQ:AMGN	Amgen Inc.
01/10/2009	19h22	Dow Jones News	Hospira Learning Valuable Lessons In European Biosimilar Market	NASDAQ:AMGN	Amgen Inc.
24/09/2009	09h37	PR Newswire (US)	Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorecta	NASDAQ:AMGN
23/09/2009	16h22	Dow Jones News	Conflicting Erbitux Study Data Hurts Merck Shares	NASDAQ:AMGN	Amgen Inc.
23/09/2009	11h59	Dow Jones News	Merck Shares Rise On Positive Erbitux Data For Colon Cancer	NASDAQ:AMGN	Amgen Inc.
22/09/2009	13h28	Dow Jones News	Amgen's Denosumab Aids Bones In Breast-Cancer Patients	NASDAQ:AMGN	Amgen Inc.